Global Antihyperlipidemic Drugs Market Insights, Trends, Growth and Forecast 2025-2033
Market OverviewThe global antihyperlipidemic drugs market reached a valuation of USD 13.1 Billion in 2024. IMARC Group forecasts the market to reach USD 18.6 Billion by 2033, representing a CAGR of 3.9% during the period 2025-2033. North America accounted for over 32.7% of the global market in 2024. This leadership is attributed to a high prevalence of cardiovascular and lipid-related...
0 Kommentare 0 Anteile 595 Ansichten 0 Vorschau